Germany will treat the use of so-called date-rape drugs like the use of a weapon — a move aimed at tougher prosecutions for sexual assault and domestic violence. The change reflects rising reports and aims to offer stronger protection to survivors.
(c) Kobby Mendez
(c) Kobby Mendez

Deutschland stuft „K.O.-Tropfen“ als Waffen ein – härtere Verfahren

THE GUARDIAN

Deutschland plant, sogenannte Vergewaltigungsdrogen künftig als Waffen zu bewerten. Damit sollen sexuelle Übergriffe und häusliche Gewalt konsequenter verfolgt und härter bestraft werden — ein klares Signal für mehr Sicherheit und Schutz für Betroffene.

Read Full Story

Related Posts

Meistgelesene Artikel

A recent Carbon Brief study shows China’s carbon dioxide emissions have remained unchanged or declined for 18 straight months, thanks in part to a surge in solar (+240 GW) and wind (+61 GW) capacity and a 5% drop in transport emissions.
Chinas CO₂-Emissionen flach oder rückläufig seit 18 Monaten
Scientists at TU Wien have developed a non-toxic “deep-eutectic” solvent that separates blended fabrics — like cotton-polyester mixes — within minutes. Cotton stays intact and polyester is recovered almost fully, offering a near-complete recycling method for textiles that were once nearly impossible to reclaim.
Neuer ungiftiger Lösemittel-Prozess könnte gemischte Textilien recycelbar machen
At COP30 in Belém, Brazil officially created ten new Indigenous territories, including some overlapping Amazon National Park. The move, issued via presidential decree, adds legal protection to lands of groups like the Munduruku and Guarani-Kaiowá during a summit marked by protests.
Brasilien weist 10 neue indigene Gebiete während COP30 aus
Researchers at the University of Cologne have discovered a powerful antibody — 04_A06 — that neutralizes around 98.5 % of over 300 tested HIV strains. In lab experiments the antibody reduced viral load to undetectable levels — a major step toward broad-spectrum therapies for prevention and treatment worldwide.
Durchbruch im Kampf gegen HIV: Antikörper blockiert fast alle Varianten